Fortress Biotech Valuation
| FBIO Stock | USD 1.68 0.07 4.35% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Fortress Biotech shows a prevailing Real Value of $12.48 per share. The current price of the firm is $1.68. Our model computes the value of Fortress Biotech from reviewing the firm fundamentals such as Shares Outstanding of 27.56 M, profit margin of (0.49) %, and Current Valuation of 59.06 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Fortress Biotech's valuation include:
Price Book 2.1922 | Enterprise Value 59.1 M | Enterprise Value Ebitda (0.29) | Price Sales 0.5613 | Enterprise Value Revenue 0.9449 |
Undervalued
Today
Please note that Fortress Biotech's price fluctuation is somewhat reliable at this time. Calculation of the real value of Fortress Biotech is based on 3 months time horizon. Increasing Fortress Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Fortress Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fortress Stock. However, Fortress Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.68 | Real 12.48 | Target 45.0 | Hype 1.67 | Naive 1.82 |
The intrinsic value of Fortress Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fortress Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fortress Biotech helps investors to forecast how Fortress stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fortress Biotech more accurately as focusing exclusively on Fortress Biotech's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Fortress Biotech's intrinsic value based on its ongoing forecasts of Fortress Biotech's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Fortress Biotech's closest peers.
Fortress Biotech Cash |
|
Fortress Valuation Trend
Knowing Fortress Biotech's actual value is paramount for traders when making sound investment determinations. Using both Fortress Biotech's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Fortress Biotech Total Value Analysis
Fortress Biotech is currently forecasted to have valuation of 59.06 M with market capitalization of 46.86 M, debt of 88.59 M, and cash on hands of 208.35 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Fortress Biotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
59.06 M | 46.86 M | 88.59 M | 208.35 M |
Fortress Biotech Investor Information
About 21.0% of the company shares are held by company insiders. The book value of Fortress Biotech was currently reported as 0.79. The company recorded a loss per share of 27.73. Fortress Biotech had not issued any dividends in recent years. The entity had 1:15 split on the 10th of October 2023. Based on the key indicators obtained from Fortress Biotech's historical financial statements, Fortress Biotech is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Fortress Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fortress Biotech has an asset utilization ratio of 50.45 percent. This suggests that the Company is making $0.5 for each dollar of assets. An increasing asset utilization means that Fortress Biotech is more efficient with each dollar of assets it utilizes for everyday operations.Fortress Biotech Ownership Allocation
Fortress Biotech holds a total of 27.56 Million outstanding shares. Fortress Biotech retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Fortress Biotech Profitability Analysis
The company reported the previous year's revenue of 84.51 M. Net Loss for the year was (60.64 M) with loss before overhead, payroll, taxes, and interest of (85.66 M).About Fortress Biotech Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Fortress Biotech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Fortress Biotech based exclusively on its fundamental and basic technical indicators. By analyzing Fortress Biotech's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Fortress Biotech's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fortress Biotech. We calculate exposure to Fortress Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fortress Biotech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 57.9 M | 60.7 M | |
| Pretax Profit Margin | (1.82) | (1.91) | |
| Operating Profit Margin | (1.68) | (1.77) | |
| Net Loss | (0.72) | (0.75) | |
| Gross Profit Margin | 0.68 | 0.44 |
Fortress Biotech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 8.1 M |
Fortress Biotech Current Valuation Indicators
Fortress Biotech's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Fortress Biotech's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Fortress Biotech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Fortress Biotech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Fortress Biotech's worth.When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.73) | Revenue Per Share 6.15 | Quarterly Revenue Growth (0.14) | Return On Assets (0.36) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.